Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Neuroscience (ANRO) Other Non-Current Assets (2024 - 2026)

Alto Neuroscience has reported Other Non-Current Assets over the past 3 years, most recently at $500000.0 for Q1 2026.

  • Quarterly results put Other Non-Current Assets at $500000.0 for Q1 2026, changed 0.0% from a year ago — trailing twelve months through Mar 2026 was $500000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $338000.0, down 32.4%.
  • Other Non-Current Assets reached $500000.0 in Q1 2026 per ANRO's latest filing, up from $338000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $570000.0 in Q2 2025 and bottomed at $4000.0 in Q2 2024.
  • Median Other Non-Current Assets over the past 3 years was $500000.0 (2024), compared with a mean of $385555.6.
  • Peak annual rise in Other Non-Current Assets hit 14150.0% in 2025, while the deepest fall reached 32.4% in 2025.
  • Over 3 years, Other Non-Current Assets stood at $500000.0 in 2024, then crashed by 32.4% to $338000.0 in 2025, then skyrocketed by 47.93% to $500000.0 in 2026.
  • Business Quant data shows Other Non-Current Assets for ANRO at $500000.0 in Q1 2026, $338000.0 in Q4 2025, and $500000.0 in Q3 2025.